Viking Therapeutics, Inc. (VKTX)
34.87
+0.89
(+2.62%)
USD |
NASDAQ |
Sep 04, 16:00
34.87
0.00 (0.00%)
After-Hours: 20:00
Viking Therapeutics Cash and Short Term Investments (Annual) : 705.74M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 705.74M |
| December 31, 2024 | 902.61M |
| December 31, 2023 | 362.08M |
| December 31, 2022 | 155.48M |
| December 31, 2021 | 202.10M |
| December 31, 2020 | 248.39M |
| December 31, 2019 | 275.64M |
| Date | Value |
|---|---|
| December 31, 2018 | 301.52M |
| December 31, 2017 | 20.58M |
| December 31, 2016 | 13.15M |
| December 31, 2015 | 14.10M |
| December 31, 2014 | 0.7559M |
| December 31, 2013 | 0.1796M |
| December 31, 2012 | 0.00 |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Vertex Pharmaceuticals, Inc. | 6.611B |
| Eli Lilly & Co. | 7.268B |
| Regeneron Pharmaceuticals, Inc. | 8.611B |
| Amgen, Inc. | 9.129B |
| Ironwood Pharmaceuticals, Inc. | 215.46M |